Therapeutic treatments using the direct application of antimicrobial metal compositions
Abstract
The invention relates to the use of one or more antimicrobial metals preferably selected from silver, gold, platinum, and palladium but most preferably silver, formed with atomic disorder, and preferably in a nanocrystalline form, for reducing inflammation or infection of the mucosal membrane. The antimicrobial metal may be formulated as, or used in the form of, a nanocrystalline coating of one or more antimicrobial or noble metals, a nanocrystalline powder of one or more antimicrobial or noble metals, or a liquid or solution containing dissolved species from a nanocrystalline powder or coating of one or more antimicrobial or noble metals.
Term
Term ended
Projected expiry passed 23 April 2022, 4.4 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
97 members in 9 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 28588401 | United States of America | P | |
| 84063701 | United States of America | A |
Members97
| Document | Office | Kind | |
|---|---|---|---|
| CA2417279A1 | Canada | A1 | |
| WO0209729A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU7832201A | Australia | A | |
| US2002051824A1 | United States of America | A1 | |
| CA2443587A1 | Canada | A1 | |
| CA2445729A1 | Canada | A1 | |
| CA2445734A1 | Canada | A1 | |
| CA2445740A1 | Canada | A1 | |
| WO02085299A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO02085384A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO02085385A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO02085386A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO02085387A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2002249046A1 | Australia | A1 | |
| US2002182265A1 | United States of America | A1 | |
| WO0209729A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2002192298A1 | United States of America | A1 | |
| WO02085385A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO02085386A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO02085387A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2003021854A1 | United States of America | A1 | |
| US2003054046A1 | United States of America | A1 | |
| US2003072810A1 | United States of America | A1 | |
| EP1303283A2 | European Patent Office (EPO) | A2 | |
| US2003086977A1 | United States of America | A1 | |
| US2003099718A1 | United States of America | A1 | |
| WO02085384A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2003170314A1 | United States of America | A1 | |
| US2003180378A1 | United States of America | A1 | |
| US2003180379A1 | United States of America | A1 | |
| US2003185901A1 | United States of America | A1 | |
| US2003194444A1 | United States of America | A1 | |
| WO02085299A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2003203046A1 | United States of America | A1 | |
| US2003206966A1 | United States of America | A1 | |
| EP1383520A2 | European Patent Office (EPO) | A2 | |
| EP1383521A2 | European Patent Office (EPO) | A2 | |
| EP1383522A2 | European Patent Office (EPO) | A2 | |
| US6692773B2 | United States of America | B2 | |
| JP2004505057A | Japan | A | |
| EP1390013A2 | European Patent Office (EPO) | A2 | |
| US6723350B2 | United States of America | B2 | |
| CA2500836A1 | Canada | A1 | |
| WO2004037187A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2003287183A1 | Australia | A1 | |
| AU2003287183A8 | Australia | A8 | |
| US2004129112A1 | United States of America | A1 | |
| US2004131698A1 | United States of America | A1 | |
| WO2004037187A8 | World Intellectual Property Organization (WIPO) | A8 | |
| US2004157073A1 | United States of America | A1 | |
| JP2004525980A | Japan | A | |
| WO2004037187A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2004176312A1 | United States of America | A1 | |
| JP2004529929A | Japan | A | |
| JP2004529930A | Japan | A | |
| US2004191329A1 | United States of America | A1 | |
| EP1303283B1 | European Patent Office (EPO) | B1 | |
| ATE282420T1 | Austria | T1 | |
| DE60107253D1 | Germany | D1 | |
| EP1390013A4 | European Patent Office (EPO) | A4 | |
| JP2005507368A | Japan | A | |
| ES2231528T3 | Spain | T3 | |
| US2005129624A1 | United States of America | A1 | |
| US2005136128A1 | United States of America | A1 | |
| WO2005074949A1 | World Intellectual Property Organization (WIPO) | A1 | |
| US6939568B2 | United States of America | B2 | |
| EP1575552A2 | European Patent Office (EPO) | A2 | |
| DE60107253T2 | Germany | T2 | |
| US2005271743A1 | United States of America | A1 | |
| AU2001278322B2 | Australia | B2 | |
| US6989156B2 | United States of America | B2 | |
| US6989157B2 | United States of America | B2 | |
| US7001617B2 | United States of America | B2 | |
| US7008647B2 | United States of America | B2 | |
| EP1383522B1 | European Patent Office (EPO) | B1 | |
| ATE322274T1This record | Austria | T1 | |
| US2006083777A1 | United States of America | A1 | |
| US2006083792A1 | United States of America | A1 | |
| DE60210441D1 | Germany | D1 | |
| US2006115541A1 | United States of America | A1 | |
| US7078060B2 | United States of America | B2 | |
| US7087249B2 | United States of America | B2 | |
| US2006204591A1 | United States of America | A1 | |
| DE60210441T2 | Germany | T2 | |
| ES2261659T3 | Spain | T3 | |
| CA2417279C | Canada | C | |
| US7201925B2 | United States of America | B2 | |
| AU2002252881B2 | Australia | B2 | |
| AU2002252879B2 | Australia | B2 | |
| US7255881B2 | United States of America | B2 | |
| AU2002303438B2 | Australia | B2 | |
| US2008014286A1 | United States of America | A1 | |
| US7427416B2 | United States of America | B2 | |
| US7470437B2 | United States of America | B2 | |
| EP1575552A4 | European Patent Office (EPO) | A4 | |
| CA2445729C | Canada | C | |
| EP1383520B1 | European Patent Office (EPO) | B1 |
2 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Change in the person of patent ownerEEIH | EEIH | |
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 2721904
Titles2
- German
- ARZNEIMITTEL ODER PFLASTER ENTHALTEND EIN METALL WIE SILBER GOLD, PLATIN ODER PALLADIUM ALS ANTIMIKROBIELLEN WIRKSTOFF UND DESSEN VERWENDUNG IN DER BEHANDLUNG VON HAUTENTZÜNDUNGEN
- English
- MEDICINAL PRODUCTS OR PLASTERS CONTAINING A METAL SUCH AS SILVER, GOLD, PLATINUM OR PALLADIUM AS ANTIMICROBIAL ACTIVE SUBSTANCE AND ITS USE IN THE TREATMENT OF SKIN INFLAMMATIONS
Classification
- CPC, 52
- A61K9/0024
- A01N59/16
- A61K9/0019
- A61K9/0075
- A61K9/0078
- A61K9/14
- A61K9/7007
- A61K33/24
- A61K33/38
- A61K33/40
- A61K47/34
- A61K47/38
- A61L15/46
- A61L17/145
- A61L27/30
- A61L29/10
- A61L31/082
- A61L2300/102
- A61L2300/104
- A61L2300/404
- A61L2300/452
- A61L2300/606
- A61L2300/624
- A61L2300/63
- Y10S424/15
- Y10T428/31855
- A61P1/00
- A61P1/02
- A61P11/00
- A61P11/02
- A61P11/04
- A61P13/00
- A61P13/08
- A61P15/00
- A61P17/00
- A61P17/02
- A61P17/04
- A61P17/06
- A61P17/08
- A61P17/10
- A61P19/00
- A61P19/02
- A61P27/16
- A61P29/00
- A61P31/00
- A61P31/04
- A61P31/10
- A61P35/00
- A61P43/00
- A61P9/00
- A61K33/242
- A61K33/243
- IPC, 47
- A61K9 02
- A61K9 00
- A61K9 06
- A61K9 08
- A61K9 10
- A61K9 107
- A61K9 12
- A61K9 14
- A61K9 16
- A61K9 20
- A61K9 51
- A61K9 68
- A61K9 70
- A61K33 38
- A61K33 40
- A61K47 34
- A61K47 38
- A61L15 44
- A61L15 46
- A61L17 14
- A61L27 30
- A61L29 10
- A61L31 08
- A61P1 00
- A61P1 02
- A61P9 00
- A61P11 00
- A61P11 02
- A61P11 04
- A61P13 00
- A61P13 08
- A61P15 00
- A61P17 00
- A61P17 02
- A61P17 04
- A61P17 06
- A61P17 08
- A61P17 10
- A61P19 00
- A61P19 02
- A61P27 16
- A61P29 00
- A61P31 00
- A61P31 04
- A61P31 10
- A61P35 00
- A61P43 00